✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Valganciclovir hydrochloride

Valganciclovir hydrochloride

CAS 175865-59-5C14H23ClN6O5MW 390.82

Valganciclovir hydrochloride (CAS 175865-59-5) — formula C14H23ClN6O5, molecular weight 390.82; category organic chemicals.

Product Overview

CAS Number175865-59-5
Molecular FormulaC14H23ClN6O5
Molecular Weight390.82
CategoryOrganic Chemicals

Technical Profile

What this product is

Valganciclovir hydrochloride is a carbon-based organic compound with CAS registry number 175865-59-5 and molecular formula C14H23ClN6O5 (molecular weight 390.82), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 175865-59-5

Its molecular formula C14H23ClN6O5 comprises 14 C, 23 H, 1 Cl, 6 N, 5 O atoms.

Also known as: Valganciclovir hydrochloride · 盐酸缬更昔洛韦

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Valganciclovir hydrochloride?

The CAS registry number of Valganciclovir hydrochloride is 175865-59-5.

What is the molecular formula and molecular weight of Valganciclovir hydrochloride?

Molecular formula C14H23ClN6O5, molecular weight 390.82.

What other names is Valganciclovir hydrochloride known by?

It is also registered under: Valganciclovir hydrochloride, 盐酸缬更昔洛韦.

Which category does Valganciclovir hydrochloride belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for Valganciclovir hydrochloride (CAS 175865-59-5), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number175865-59-5
PubChem CID135413534
Molecular formulaC14H23ClN6O5
IUPAC name[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochloride
UNII (FDA)4P3T9QF9NZ

Computed descriptors

Molecular Weight390.82
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass390.1418455
Monoisotopic Mass390.1418455
Topological Polar Surface Area167
Heavy Atom Count26

Documented uses on record

    Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS. Valganciclovir hydrochloride is also FDA-approved for the prevention of CMV disease in recipients of organ transplants who are at risk for CMV diseases.CMV diseases, including CMV retinitis, can be opportunistic infections(OIs) of HIV.

    Synonyms and trade names

    Valganciclovir hydrochloride; 175865-59-5; Valganciclovir HCl; Valcyte; Valcyt; DTXSID9046784; RS 079070-194; 4P3T9QF9NZ; RS-79070-194; NSC-760349; L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, hydrochloride (1:1); RO 107-9070/194; Ro107-9070/194; RS-079070-194; VALGANCICLOVIR (AS HYDROCHLORIDE); DTXCID7026784

    GHS hazard classification

    Reported hazard statementsH340 (100%), H350 (77.8%), H351 (22.2%), H360 (88.9%), H372 (66.7%)

    H340 (100%): May cause genetic defects [Danger Germ cell mutagenicity]

    H350 (77.8%): May cause cancer [Danger Carcinogenicity]

    What the public record says

    Valganciclovir hydrochloride · CAS 175865-59-5 · C14H23ClN6O5. UNII 4P3T9QF9NZ.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 盐酸缬更昔洛韦

鲁ICP备19031700号-2